Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer.
Mitsunaga S, Ikeda M, Imaoka H, Sasaki M, Watanabe K, Sato A, Aoki K, Ochiai A, Makikawa M, Nishidate M, Yamaguchi K, Terao K, Sawada N, Fujitomo T, Fujii E, Kato A, Tsunoda H.
Mitsunaga S, et al. Among authors: makikawa m.
Cancer Sci. 2023 Oct;114(10):4006-4019. doi: 10.1111/cas.15929. Epub 2023 Aug 21.
Cancer Sci. 2023.
PMID: 37605479
Free PMC article.